Boyle; Francis Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boyle; Francis Thomas.The latest application filed is for "n-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyri- dine-3 sulphonamide as an anticancer agent".

Company Profile

0.13.16

Boyle; Francis Thomas - Macclesfield GB
Boyle; Francis Thomas - Cheshire GB
Boyle; Francis Thomas - Macclesfield Cheshire GB
Boyle, Francis Thomas - Congleton GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyri- Dine-3 Sulphonamide As An Anticancer Agent App 20110003831 - Tonge; David Williams ; et al.	2011-01-06
N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl-phenyl)pyri- dine-3 sulphonamide as an anticancer agent Grant 7,820,679 - Tonge , et al. October 26, 2	2010-10-26
Combination of N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyri- dine-3-sulphonamide and an anti-mitotic cytotoxic agent App 20100035896 - Curwen; John ; et al.	2010-02-11
4-substituted quinolines as antitumor agents Grant 7,504,416 - Boyle , et al. March 17, 2	2009-03-17
Indolylalkylamino-methylidenecarbamate derivatives useful as GnRH antagonists Grant 7,449,489 - Boyle , et al. November 11, 2	2008-11-11
Substituted quinolines as antitumor agents Grant 7,402,583 - Boyle , et al. July 22, 2	2008-07-22
Combination of N-(3-Methoxy-5-Methylpyrazin-2-Yl)-2-(4-[1,3,4-Oxadiazol-2-Yl]Phenyl)Pyri- dine-3-Sulphonamide and an Anti-Mitotic Cytotoxic Agent App 20080076780 - Curwen; John ; et al.	2008-03-27
4-Substituted quinolines as antitumor agents App 20080027054 - Boyle; Francis Thomas ; et al.	2008-01-31
4-Substituted quinolines as antitumor agents Grant 7,253,184 - Boyle , et al. August 7, 2	2007-08-07
Substituted quinolines as antitumor agents App 20070021407 - Boyle; Francis Thomas ; et al.	2007-01-25
Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists App 20060258710 - Boyle; Francis Thomas ; et al.	2006-11-16
Farnesyl transferase inhibitors Grant 7,101,897 - Wardleworth , et al. September 5, 2	2006-09-05
Substituted quinolines as antitumor agents Grant 7,067,532 - Boyle , et al. June 27, 2	2006-06-27
Therapeutic treatment App 20060122180 - Boyle; Francis Thomas ; et al.	2006-06-08
N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyri- dine-3 sulphonamide as an anticancer agent App 20060094729 - Tonge; David William ; et al.	2006-05-04
Indole derivatives with vascular damaging activity Grant 7,030,123 - Arnould , et al. April 18, 2	2006-04-18
3-Mercaptopyrrolidines as farnesyl protein transferase inhibitors App 20050209217 - Boyle, Francis Thomas ; et al.	2005-09-22
3-mercaptopyrrolidines as farnesyl protein transferase inhibitors Grant 6,946,468 - Boyle , et al. September 20, 2	2005-09-20
4-Substituted quinolines as antitumor agents App 20050101630 - Boyle, Francis Thomas ; et al.	2005-05-12
Inhibitors of farnesyl protein transferase Grant 6,777,438 - Wardleworth , et al. August 17, 2	2004-08-17
Cyclin dependent kinase inhibiting purine derivatives App 20040110775 - Griffin, Roger John ; et al.	2004-06-10
Substituted quinolines as antitumor agents App 20040029898 - Boyle, Francis Thomas ; et al.	2004-02-12
Inhibitors of farnesyl protein transferase App 20030220495 - Boyle, Francis Thomas ; et al.	2003-11-27
Indole derivatives with vascular damaging activity App 20030216356 - Arnould, Jean-Claude ; et al.	2003-11-20
Inhibitors of farnesyl protein transferase App 20030096842 - Wardleworth, James Michael ; et al.	2003-05-22
Farnesyl transferase inhibitors App 20030083348 - Wardleworth, James Michael ; et al.	2003-05-01
4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors Grant 6,541,491 - Davies , et al. April 1, 2	2003-04-01
Chemical compounds Grant 5,985,281 - Taylorson , et al. November 16, 1	1999-11-16
Tricyclic compounds with pharmaceutical activity Grant 5,789,417 - Boyle , et al. August 4, 1	1998-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.